Molnupiravir

ANTIINFECTIVES FOR SYSTEMIC USE

Key facts

Molnupiravir is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2021. Recorded indications include COVID-19.

• Indications: COVID-19.
• ATC code: J05AB18 (Nucleosides and nucleotides excl. reverse transcriptase inhibitors).
• Molecular formula: C13H19N3O7; molecular weight 329.31 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• COVID-19

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
2021-12-24	PMDA	—	MSD K.K.

ATC classification

ATC code	Therapeutic hierarchy
J05AB18	ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
No adverse event	1824.2
Product use issue	1457.7
Accidental underdose	1176.8
Wrong technique in product usage process	1035.8
Product use complaint	909.4
COVID-19	666.3
Underdose	422.2
Product use in unapproved indication	412.6
Accidental overdose	377.7
COVID-19 pneumonia	289.5
Product prescribing issue	270.8
Incorrect product administration duration	213.3

Chemical structure

• Molecular formula: C₁₃H₁₉N₃O₇
• Molecular weight: 329.31 g/mol
• CAS number: —
• InChIKey: HTNPEHXGEKVIHG-QCNRFFRDSA-N
• PubChem CID: 145996610

CC(C)C(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(NO)=NC1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Molnupiravir used for?

DrugCentral lists the following indications for Molnupiravir: COVID-19.

When was Molnupiravir first approved?

Molnupiravir was first approved by the PMDA in 2021.

What is the chemical formula of Molnupiravir?

Molnupiravir has the molecular formula C13H19N3O7 and a molecular weight of 329.31 g/mol.

Sources

• DrugCentral drug card 5377 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL4650320 — compound record and bioactivity
• PubChem CID 145996610 — chemical identifiers
• DrugBank DB15660 — drug record
• FDA UNII YA84KI1VEW — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.